Coherus Biosciences reported $79.03M in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 124.99M 6.86M
Ironwood Pharmaceuticals IRWD:US $ 147.4M 14.3M
LG Chem 051910:KS KW 15062096M 196652M
Myriad Genetics MYGN:US $ 204.3M 1.1M
Teva Pharmaceutical TEVA:IT 11.03B 798M
Xencor XNCR:US $ 60.94M 9.8M
Zoetis ZTS:US $ 1797M 326M